Tracking antibiotic resistance in the DRC
Part of Infections clinical trials.
This study looks for antibiotic-resistant bacteria in the blood of patients with a suspected bloodstream infection. The goal is to understand which antibiotics still work, helping doctors choose the right treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are older than 6 months.
- You have a bloodstream infection suspected by a doctor at the hospital.
- You just arrived at the hospital or have been there for less than 2 days.
- You (or your guardian) can give permission to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at how to better care for people with fever in the Democratic Republic of the Congo. If you have a fever now or very recently, you may be able to join and help doctors learn more about it.
This trial looks at different ways to control mosquitoes that spread diseases. It will see how well these methods work in households and health facilities in Kinshasa.
This study collects and studies lab-detected germs in hospital patients that produce special enzymes making some antibiotics less effective. It helps researchers understand how these resistant germs spread over time in Switzerland.
This study looks at wastewater from a hospital to track antibiotic-resistant bacteria. By analyzing these samples, researchers hope to create an early warning system to improve infection control and protect patients.
This study tests a new rapid test to detect plague faster and more easily. It aims to help doctors diagnose and treat plague sooner in areas where it occurs.
This trial is testing a new method (IDBIORIV) to quickly identify the germs causing sepsis and find the right antibiotic. It aims to help patients with a confirmed bloodstream infection get the most effective treatment faster.
Hear when a new Bacteremia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.